Dark Forest Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Dark Forest Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-119,127	Closed	-$515K	–	1092
2023 Q3	$515K	Buy	119,127 +85,462	+254%	+$475K	0.04%	703
2023 Q2	$222K	Buy	+33,665	New	+$216K	0.02%	911
2022 Q3	–	Sell	-12	Closed	–	–	1451
2022 Q2	$0	Buy	+12	New	+$124	﹤0.01%	1401

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Dark Forest Capital Management's VNDA Position: Q4 2023 in Review

Dark Forest Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 119,127 shares — an estimated $515K sold.

Dark Forest Capital Management first reported a position in VNDA in Q2 2022 and held it in 3 quarters. The position peaked at $515K in Q3 2023. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.

Dark Forest Capital Management reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Dark Forest Capital Management sold 119,127 Vanda Pharmaceuticals shares in Q4 2023, an estimated $515K.
Dark Forest Capital Management first reported a position in Vanda Pharmaceuticals in Q2 2022 and held it in 3 quarters.
Dark Forest Capital Management's Vanda Pharmaceuticals position peaked at $515K in Q3 2023.
157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.

Based on Dark Forest Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.